Summary
VIANET, the vending machine technology firm, yesterday confirmed it has secured a key purchase order for 1300 of its Vitel units from drugs giant GlaxoSmithKline, for an undisclosed sum.
Shares in the Dunfermlinebased firm, which is listed on the Alternative Investment Market, soared almost 12% on the back of the deal. Glaxo placed the order after a successful six-month trial of the Vitel units.See the full content of this document
Extract
Glaxosmithkline Order Proves Vital for Vianet
The order follows the award of an order from MEI, part of c...
See the full content of this document
Sponsored links
